The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

Wegovy is an injectable medication that contains semaglutide, the same active ingredient as Ozempic, but in a slightly higher dose. However, unlike Ozempic, Wegovy is FDA approved for weight ...

Novo Nordisk cut 2025 sales forecast citing competition from compounded versions of its Wegovy weight-loss drug. Invezz takes ...

As summer approaches, millions of Americans are turning to weight-loss injections in hopes of shedding pounds—fast. Roughly ...

the active ingredient in GLP-1 drugs, including drugmaker Novo Nordisk’s Ozempic and Wegovy. The findings may be an indicator that more patient education is necessary when it comes to taking the ...

Italy and Germany, patients received doses of semaglutide, the active ingredient used to treat diabetes in Ozempic and obesity in Wegovy. The patients started on low doses and increased gradually ...

The deal is a game changer, enabling Hims to offer Wegovy at $599/month versus $1,999/month. I think this deal hints at potential to do the same with Ozempic ... the shortage list would be short ...

The pharmaceutical company that makes the weight-loss drug Wegovy and the diabetes medication Ozempic secured a court victory that limits compounding pharmacies from selling versions of those ...

it opened the door for compounding pharmacies to legally fill the gap and make copies of brand-name medications by altering some ingredients. Generic versions of Ozempic, Wegovy, and Mounjaro ...